NIH-funded research R01 grant

Platelet-driven metabolic stress and thrombo-inflammation in PAH

Official title: Platelet Metabolic Stress Induces Thrombo-Inflammation to Drive Endothelial Dysfunction in PH

Funded at University of Pittsburgh at Pittsburgh · NIH-11378581 · Data updated 2026-11-12

A project looks at how stressed platelets contribute to endothelial dysfunction and lung blood vessel disease in pulmonary arterial hypertension, with potential to reveal new targets to help patients.

More Endothelial Dysfunction research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 1, 2023
Project endJuly 31, 2027
Funding year2026
Award (this year)$706,994
NIH project number5R01HL166985-04
Project IDNIH-11378581 on NIH RePORTER

Who could benefit from this research

Could help

PAH patients or models reflecting PAH biology may be enrolled or used for comparative analyses to validate findings.

Less likely to help

The study may not directly benefit patients if results do not translate into therapies or if individuals do not fit the experimental models.

What this research studies

This research explores why the lining of lung blood vessels gets damaged in PAH by studying how platelets’ metabolism and inflammatory signals affect endothelial cells. The team will examine the role of MFN1-driven mitochondrial dysfunction in platelets, inflammasome activation, and the release of inflammatory factors that drive vascular remodeling. Using models that resemble human PAH, they will trace how platelet changes lead to NOX1-mediated oxidative stress and endothelial proliferation. The goal is to identify steps that could be targeted to prevent or lessen vessel damage and improve outcomes for people with PAH.

Why it matters

Potential benefit: If successful, the work could uncover new targets to reduce inflammation and endothelial damage in PAH, potentially slowing disease progression.

How similar studies have gone: Preliminary data in PAH models suggest platelet metabolism and inflammasome pathways influence vascular pathology, supporting further exploration.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Shiva, Sruti — University of Pittsburgh at Pittsburgh
  • Study coordinator: Shiva, Sruti

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.